Detalles de la búsqueda
1.
Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases.
Genet Med
; 24(1): 109-118, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906478
2.
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
Genet Med
; 24(6): 1349-1361, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35396982
3.
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
Genet Med
; 24(11): 2415-2417, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178484
4.
Response to Grosse and Gudgeon.
Genet Med
; 24(12): 2597-2598, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166002
5.
Development and validation of a 32-gene prognostic index for prostate cancer progression.
Proc Natl Acad Sci U S A
; 110(15): 6121-6, 2013 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23533275
6.
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
Breast Cancer Res Treat
; 154(3): 533-41, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26578401
7.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Lancet Oncol
; 14(11): 1067-1076, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035531
8.
System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model.
Expert Rev Pharmacoecon Outcomes Res
; 24(1): 37-47, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803528
9.
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 8: e2400075, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754057
10.
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
J Am Heart Assoc
; 11(12): e025236, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699184
11.
The diagnostic trajectory of infants and children with clinical features of genetic disease.
NPJ Genom Med
; 6(1): 98, 2021 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811359
12.
Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement.
Pharmacoecon Open
; 5(3): 449-458, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33689154
13.
To think or not to think: synaptic activity and Abeta release.
Neuron
; 48(6): 873-5, 2005 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-16364890
14.
Molecular testing as a tool for the management of metastatic cancer patients.
MLO Med Lab Obs
; 46(3): 8-10; quiz 11, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24696946
15.
Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action.
NPJ Genom Med
; 9(1): 23, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538605
16.
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis.
JCO Precis Oncol
; 2: 1-12, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135112
17.
Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP.
J Neurosci
; 26(52): 13428-36, 2006 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-17192425
18.
Gene expression profiling: a validated molecular complement to standard clinicopathologic evaluation in difficult-to-diagnose metastatic tumors.
MLO Med Lab Obs
; 44(9): 26-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23002507
19.
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer.
NPJ Breast Cancer
; 3: 28, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28795152
20.
A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes.
Clin Cancer Res
; 23(23): 7217-7224, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939745